药代-话题@MedSci

#药代#

158篇内容 | 3033人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1666776, encodeId=08d61666e7695, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=关于格列美脲的生物等效性和药代动力学评价, objectType=article, longId=734069, objectId=cde4e34069b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cde4e34069b1, replyNumber=0, likeNumber=59, createdTime=2022-08-14, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cde4e34069b1, moduleTitle=关于格列美脲的生物等效性和药代动力学评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cde4e34069b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666774, encodeId=e4c61666e74d2, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=联拓生物完成Mavacamten在中国健康志愿者中的I期药代动力学研究, objectType=article, longId=726512, objectId=5008e26512f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5008e26512f9, replyNumber=0, likeNumber=100, createdTime=2022-10-02, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5008e26512f9, moduleTitle=联拓生物完成Mavacamten在中国健康志愿者中的I期药代动力学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5008e26512f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666777, encodeId=0ba11666e77e5, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Neurology：静脉注射（DIZ101）、皮下注射（DIZ102）和肠内注射（LCIG）的左旋多巴的药代动力学帕金森氏症, objectType=article, longId=734049, objectId=0064e34049af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0064e34049af, replyNumber=0, likeNumber=89, createdTime=2023-04-04, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0064e34049af, moduleTitle=Neurology：静脉注射（DIZ101）、皮下注射（DIZ102）和肠内注射（LCIG）的左旋多巴的药代动力学帕金森氏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0064e34049af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666775, encodeId=a4251666e757b, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=JAC：雌激素治疗对替诺福韦和恩曲他滨血浆药代动力学的影响, objectType=article, longId=733207, objectId=c33ee3320764, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c33ee3320764, replyNumber=0, likeNumber=83, createdTime=2023-03-18, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c33ee3320764, moduleTitle=JAC：雌激素治疗对替诺福韦和恩曲他滨血浆药代动力学的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c33ee3320764)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666778, encodeId=bd401666e7843, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=【每日播报】-常用ARB的药代动力学, objectType=article, longId=737645, objectId=94e1e3764531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94e1e3764531, replyNumber=0, likeNumber=45, createdTime=2023-08-19, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94e1e3764531, moduleTitle=【每日播报】-常用ARB的药代动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94e1e3764531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666773, encodeId=2ea01666e7358, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Ann Hematol：造血干细胞移植患者的固定剂量给药和药代动力学指导调整白消安剂量具有更高的功效、安全性和成本效益, objectType=article, longId=295383, objectId=932c295383ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=932c295383ba, replyNumber=0, likeNumber=146, createdTime=2022-06-15, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=932c295383ba, moduleTitle=Ann Hematol：造血干细胞移植患者的固定剂量给药和药代动力学指导调整白消安剂量具有更高的功效、安全性和成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=932c295383ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666769, encodeId=f7eb1666e69cf, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=CID：马拉韦罗在HIV-1感染孕妇体内的药代动力学变化, objectType=article, longId=217664, objectId=11f921e664de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11f921e664de, replyNumber=0, likeNumber=93, createdTime=2022-05-23, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11f921e664de, moduleTitle=CID：马拉韦罗在HIV-1感染孕妇体内的药代动力学变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11f921e664de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666772, encodeId=57c01666e726c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=AHA 2021丨MK-0616（一种口服PCSK9抑制剂）的临床安全性、药代动力学和降低低密度脂蛋白胆固醇的疗效, objectType=article, longId=220423, objectId=65e722042367, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65e722042367, replyNumber=0, likeNumber=81, createdTime=2021-11-30, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65e722042367, moduleTitle=AHA 2021丨MK-0616（一种口服PCSK9抑制剂）的临床安全性、药代动力学和降低低密度脂蛋白胆固醇的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65e722042367)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666770, encodeId=42621666e7087, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Nat Med：依拉曲韦皮下植入治疗用于HIV-1预防的安全性和药代动力学, objectType=article, longId=218210, objectId=edb321821014, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edb321821014, replyNumber=0, likeNumber=75, createdTime=2022-08-29, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edb321821014, moduleTitle=Nat Med：依拉曲韦皮下植入治疗用于HIV-1预防的安全性和药代动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edb321821014)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666771, encodeId=6a071666e7147, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=药代动力学及药理作用：小檗碱治疗糖尿病, objectType=article, longId=219677, objectId=30492196e713, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30492196e713, replyNumber=0, likeNumber=129, createdTime=2022-04-25, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30492196e713, moduleTitle=药代动力学及药理作用：小檗碱治疗糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30492196e713)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666768, encodeId=1b581666e6899, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Radiology：人工智能在星形细胞瘤DCE MRI药代动力学参数中的应用, objectType=article, longId=214487, objectId=ab1021448eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab1021448eb0, replyNumber=0, likeNumber=104, createdTime=2021-10-08, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab1021448eb0, moduleTitle=Radiology：人工智能在星形细胞瘤DCE MRI药代动力学参数中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab1021448eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666765, encodeId=12b91666e6527, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=殊途同归——中日医药代表新规比较, objectType=article, longId=204070, objectId=56a52040e0d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56a52040e0d6, replyNumber=0, likeNumber=83, createdTime=2021-02-16, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56a52040e0d6, moduleTitle=殊途同归——中日医药代表新规比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56a52040e0d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666763, encodeId=93a81666e633d, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=《医药代表备案管理办法（试行）》，不得统方! 不得卖药! 不得提供赞助!, objectType=article, longId=201424, objectId=6f18201424e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f18201424e6, replyNumber=0, likeNumber=66, createdTime=2020-10-24, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f18201424e6, moduleTitle=《医药代表备案管理办法（试行）》，不得统方! 不得卖药! 不得提供赞助!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f18201424e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666766, encodeId=fbc41666e66a1, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=今日，医药代表备案制正式施行, objectType=article, longId=204071, objectId=bf932040e188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf932040e188, replyNumber=0, likeNumber=71, createdTime=2021-02-06, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf932040e188, moduleTitle=今日，医药代表备案制正式施行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf932040e188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666762, encodeId=3a051666e62b9, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=中纪委：彻查医疗腐败，打击一批药代, objectType=article, longId=198862, objectId=7d4f1988629c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d4f1988629c, replyNumber=0, likeNumber=68, createdTime=2021-04-08, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d4f1988629c, moduleTitle=中纪委：彻查医疗腐败，打击一批药代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d4f1988629c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666760, encodeId=2dae1666e6091, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Nat BME: 通过流体耦合血管化器官芯片定量预测药物对人体药代动力学的影响, objectType=article, longId=197830, objectId=76d119e83048, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76d119e83048, replyNumber=0, likeNumber=86, createdTime=2020-08-18, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76d119e83048, moduleTitle=Nat BME: 通过流体耦合血管化器官芯片定量预测药物对人体药代动力学的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76d119e83048)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666764, encodeId=328a1666e64f9, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医药代表备案制即将出台，追根朔源回归学术价值, objectType=article, longId=202915, objectId=df4b20291520, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df4b20291520, replyNumber=0, likeNumber=90, createdTime=2021-10-18, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df4b20291520, moduleTitle=医药代表备案制即将出台，追根朔源回归学术价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df4b20291520)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666767, encodeId=cfbe1666e67c6, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=药代备案制后，诺华、罗氏调整团队, objectType=article, longId=204103, objectId=e26120410318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e26120410318, replyNumber=0, likeNumber=73, createdTime=2021-07-12, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e26120410318, moduleTitle=药代备案制后，诺华、罗氏调整团队, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e26120410318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666761, encodeId=b4391666e61b1, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=群体药代研究技术指导原则征求意见稿, objectType=article, longId=198696, objectId=d747198696a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d747198696a2, replyNumber=0, likeNumber=114, createdTime=2020-08-12, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d747198696a2, moduleTitle=群体药代研究技术指导原则征求意见稿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d747198696a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666754, encodeId=00ce1666e547b, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医药代表，先别换工作, objectType=article, longId=188755, objectId=f869188e5570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f869188e5570, replyNumber=0, likeNumber=69, createdTime=2020-09-11, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f869188e5570, moduleTitle=医药代表，先别换工作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f869188e5570)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药代

2020-05-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

关于格列美脲的生物等效性和药代动力学评价

2022-08-14

fengyqf (审核中...)

前往app查看评论内容

#药代#

联拓生物完成Mavacamten在中国健康志愿者中的I期药代动力学研究

2022-10-02

fengyqf (审核中...)

前往app查看评论内容

#药代#

Neurology：静脉注射（DIZ101）、皮下注射（DIZ102）和肠内注射（LCIG）的左旋多巴的药代动力学帕金森氏症

2023-04-04

fengyqf (审核中...)

前往app查看评论内容

#药代#

JAC：雌激素治疗对替诺福韦和恩曲他滨血浆药代动力学的影响

2023-03-18

fengyqf (审核中...)

前往app查看评论内容

#药代#

【每日播报】-常用ARB的药代动力学

2023-08-19

fengyqf (审核中...)

前往app查看评论内容

#药代#

Ann Hematol：造血干细胞移植患者的固定剂量给药和药代动力学指导调整白消安剂量具有更高的功效、安全性和成本效益

2022-06-15

fengyqf (审核中...)

前往app查看评论内容

#药代#

CID：马拉韦罗在HIV-1感染孕妇体内的药代动力学变化

2022-05-23

fengyqf (审核中...)

前往app查看评论内容

#药代#

AHA 2021丨MK-0616（一种口服PCSK9抑制剂）的临床安全性、药代动力学和降低低密度脂蛋白胆固醇的疗效

2021-11-30

fengyqf (审核中...)

前往app查看评论内容

#药代#

Nat Med：依拉曲韦皮下植入治疗用于HIV-1预防的安全性和药代动力学

2022-08-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

药代动力学及药理作用：小檗碱治疗糖尿病

2022-04-25

fengyqf (审核中...)

前往app查看评论内容

#药代#

Radiology：人工智能在星形细胞瘤DCE MRI药代动力学参数中的应用

2021-10-08

柳叶一刀 (审核中...)

前往app查看评论内容

#药代#

殊途同归——中日医药代表新规比较

2021-02-16

fengyqf (审核中...)

前往app查看评论内容

#药代#

《医药代表备案管理办法（试行）》，不得统方! 不得卖药! 不得提供赞助!

2020-10-24

fengyqf (审核中...)

前往app查看评论内容

#药代#

今日，医药代表备案制正式施行

2021-02-06

fengyqf (审核中...)

前往app查看评论内容

#药代#

中纪委：彻查医疗腐败，打击一批药代

2021-04-08

fengyqf (审核中...)

前往app查看评论内容

#药代#

Nat BME: 通过流体耦合血管化器官芯片定量预测药物对人体药代动力学的影响

2020-08-18

fengyqf (审核中...)

前往app查看评论内容

#药代#

医药代表备案制即将出台，追根朔源回归学术价值

2021-10-18

fengyqf (审核中...)

前往app查看评论内容

#药代#

药代备案制后，诺华、罗氏调整团队

2021-07-12

fengyqf (审核中...)

前往app查看评论内容

#药代#

群体药代研究技术指导原则征求意见稿

2020-08-12

fengyqf (审核中...)

前往app查看评论内容

#药代#

医药代表，先别换工作

2020-09-11

科室
- - 订阅+
  - 更多科室
工具
服务